Investing Ideas
/
Norwegian Pharmaceuticals & Biotech Financially Fit Penny Stocks

Norwegian Pharmaceuticals & Biotech Financially Fit Penny Stocks

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

A Penny Stocks screener, typically smaller or younger companies trading at a price below 5, with a focus on solid financial health that should present companies with a lower risk profile than other early-stage businesses

5 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
ABS Arctic Bioscience	NOK 3.28	-0.6%	-67.5%	NOK 86.3m	n/a	PS2.6x	E-12.8%	n/a
NYKD Nykode Therapeutics	NOK 2.63	-4.6%	-85.3%	NOK 861.4m	NOK 10.63	PS17.4x	E-2.3%	n/a
PCIB PCI Biotech Holding	NOK 1.22	0%	-40.3%	NOK 45.9m	n/a	PS7.6x	n/a	n/a
EXTX EXACT Therapeutics	NOK 3.22	-2.4%	-73.2%	NOK 203.7m	n/a	PB11.7x	n/a	n/a
TRMED Thor Medical	NOK 2.61	-7.3%	127.0%	NOK 817.5m	n/a	PB3.2x	n/a	n/a

Page 1 of 1